Calcitonin gene-related peptide is an inhibitor of aldosterone secretion

Endocrinology. 1989 Oct;125(4):2227-9. doi: 10.1210/endo-125-4-2227.

Abstract

This study examined the effects of calcitonin gene-related peptide (CGRP) on aldosterone secretion both in vivo and in vitro. Intravenous administration of CGRP (0.01 micrograms/kg) in 6 conscious dogs produced a significant decrease in plasma aldosterone concentration from 68 +/- 12 pg/ml to 28 +/- 11 pg/ml (p less than 0.05) despite a mild but significant elevation of plasma renin activity. In an in vitro study using isolated rabbit adrenal glomerulosa cells CGRP reduced the basal aldosterone secretion in a dose-related manner and furthermore 10(-9) M CGRP inhibited the aldosterone secretion stimulated by 10(-8) M angiotensin II. From these results it is suggested that CGRP has an inhibitory effect on aldosterone secretion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldosterone / blood
  • Aldosterone / metabolism
  • Animals
  • Calcitonin Gene-Related Peptide / pharmacology*
  • Cells, Cultured
  • Dogs
  • Female
  • Male
  • Mineralocorticoid Receptor Antagonists / pharmacology*
  • Osmolar Concentration
  • Rabbits
  • Zona Glomerulosa / cytology
  • Zona Glomerulosa / metabolism

Substances

  • Mineralocorticoid Receptor Antagonists
  • Aldosterone
  • Calcitonin Gene-Related Peptide